WELCOME TO THE SACT SAFETY CAMPAIGN
Our aim is simple. We want to see clinicians throughout the UK properly protected from harm when they administer cytotoxic systemic anti-cancer therapy (SACT) through the use of closed system drug transfer devices (CSDTDs)
EVERY TREATMENT. EVERY DAY. EVERY TIME.
What is a closed system drug transfer device?
CSDTD is defined as a drug transfer device that mechanically prohibits the transfer of environmental contaminants into the system and the escape of hazardous drug or vapour concentrations outside the system (NIOSH 2004)